In silico modeling and simulation of neuroendocrine-immune modulation through adrenergic and 17β-estradiol receptors in lymphocytes show differential activation of cyclic adenosine monophosphate (cAMP)
Authors:
- H. P. PriyankaHPH. P. Priyanka
- A. ThiyagarajATA. Thiyagaraj
- R.S. NairRNR.S. Nair
- W. HopperWHW. Hopper
Preprint
Abstract
Sympathetic innervation of lymphoid organs and presence of 17β-estradiol (estrogen or E 2 ) and adrenergic receptors (ARs) on lymphocytes suggests that sympathetic stimulation and hormonal activation may influence immune functions. Simulation of these pathways may help to understand the dynamics of neuroendocrine-immune modulation at the cellular and molecular level. Dose- and receptor-dependent effects of 17β-estradiol and AR sub-type-specific agonists were established in vitro on lymphocytes from young male Sprague-Dawley rats and modeled in silico using MATLAB Simbiology toolbox. Kinetic principles were assigned to define receptor-ligand dynamics and concentration/time plots were obtained using Ode15s solvers at different time intervals for key regulatory molecules. Comparisons were drawn between in silico and in vitro data for validating the constructed model with sensitivity analysis of key regulatory molecules to assess their individual impacts on the dynamics of the system. Adrenergic activation triggered pro-apoptotic signals while 17β-estradiol enhanced survival signals showing contradictory effects as observed in vitro. Treatment of lymphocytes with 17β-estradiol shows ten-fold increase in survival signals in a dose-dependent manner. cAMP (cyclic adenosine monophosphate) activation is crucial for the activation of survival signals through p-ERK (Extracellular Signal-Regulated Kinase) and p-CREB (cAMP Responsive Element Binding) protein. Thus, the cross-talk between 17β-estradiol and adrenergic signaling pathways determines lymphocyte functions in a receptor subtype- and co-activation-dependent manner in health and disease.Keywords
This publication has 55 references indexed in Scilit:
- The beta2-adrenergic receptor on T and B lymphocytes: Do we understand it yet?Brain, Behavior, and Immunity, 2012
- Oestrogen Signalling and Neuroprotection in Cerebral IschaemiaJournal of Neuroendocrinology, 2011
- Age-associated alterations in sympathetic noradrenergic innervation of primary and secondary lymphoid organs in female Fischer 344 ratsJournal of Neuroimmunology, 2011
- In vivo effects of a GPR30 antagonistNature Chemical Biology, 2009
- Autonomic innervation and regulation of the immune system (1987–2007)Brain, Behavior, and Immunity, 2007
- α1-Adrenergic Receptor Subtypes in Human Peripheral Blood LymphocytesHypertension, 1999
- Up‐regulation of a constitutively active form of the β2‐adrenoceptor by sustained treatment with inverse agonists but not antagonistsFEBS Letters, 1996
- T-lymphocyte immunointerferon receptors in patients with multiple sclerosisJournal of Neurology, 1996
- Effects of medetomidine, an α-2 adrenoceptor agonist, and atipamezole, an α-2 antagonist, on spatial memory performance in adult and aged ratsBehavioral and Neural Biology, 1992
- Alterations in the proestrous pattern of median eminence LHRH, serum LH, FSH, estradiol and progesterone concentrations in middle-aged ratsLife Sciences, 1982